Induced Overexpression of B Cell-Activating Factor by Triiodothyronine Results in Abnormal B Cell Differentiation in Mice
Breakdown of tolerance and abnormal activation in B cells is an important mechanism in the pathogenesis of Graves’ disease (GD) and high levels of thyroid hormones (THs) can drive the progression of GD. However, the interactions between THs and abnormal activation of B cells in the context of GD are...
Main Authors: | Shu Liu, Guo-Qing Li, Qing-Wei Gu, Jie Wang, Qi Sun, Wen-Sha Gu, Xiao-Ming Mao |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-10-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/09636897231204075 |
Similar Items
-
Activation of Toll‐like receptor 4 by thyroid hormone triggers abnormal B‐cell activation
by: Jie Wang, et al.
Published: (2023-09-01) -
High free triiodothyronine, and free-triiodothyronine-to-free-thyroxine ratio are associated with metabolic syndrome in a euthyroid employee population: the Zhejiang Zhenhai study
by: Qiankai Jin, et al.
Published: (2023-05-01) -
Metabolic Systemic Effects Triiodothyronine
by: E. A. Troshina, et al.
Published: (2020-07-01) -
Triiodothyronine Acts as a Smart Influencer on Hsp90 via a Triiodothyronine Binding Site
by: Lu Fan, et al.
Published: (2022-06-01) -
Abnormal B-Cell Maturation and Increased Transitional B Cells in CBL Syndrome
by: Francesco Saettini, et al.
Published: (2022-07-01)